In 2023, Dr. Charles Wu earned $106.15K in total compensation at Gyre Therapeutics, Inc., primarily from $106.15K salary.
Compensation History
Annual executive compensation data for Dr. Charles Wu, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$106.15K
Salary
$106.15K
Bonus
$0.00
Other
$0.00
Salary
$106.15KBoard Justification
The compensation program is designed to attract and retain executive talent necessary for the company's success, with a focus on aligning compensation with performance.
Bonus
$0.00Board Justification
No bonuses were paid to any NEO in respect of the 2023 performance period.
Other Compensation
$0.00Board Justification
No other compensation was reported for 2023.
Restricted Stock
Board Justification
No stock grants were vested in 2023.
Performance Metrics
No specific performance metrics were outlined for the 2023 compensation.
Dr. Charles Wu
Ex-CEO of Gyre Therapeutics, Inc.
Education
Bachelor's degree in Polymer Chemistry from University of Science and Technology of China; Doctoral degree in Chemistry from University of Maryland; MBA certificate from Tulane University.
Sector of Economy
Healthcare
Born
January 1, 1960 - 65 years ago
CEO of Gyre Therapeutics, Inc. for
0 years 2 months (Oct 2023 - Jan 2024)
Previous Experience
Chief Technology Officer at Beijing Continent Pharmaceuticals Co., Ltd.; Vice President of Active Pharmaceutical Ingredient division at Zhejiang Huahai Pharmaceutical Co., Ltd.; General Manager at Teva Pharmaceutical & Chemical (Hangzhou) Co., Ltd.
Other Gyre Therapeutics, Inc. CEOs
Holdings
Track Dr. Charles Wu's stock holdings and portfolio value over time.
Insider Trading
Dr. Charles Wu's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Dr. Charles Wu with competitor CEOs and industry peers.